121 related articles for article (PubMed ID: 37248179)
1. [Meta-analysis of Ac-SDKP inhibition of Pulmonary fibrosis in animal models].
Gong HB; Zhang CM; Tang XY; Gong RB; Miao ZY; Deng HJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Apr; 41(4):262-270. PubMed ID: 37248179
[No Abstract] [Full Text] [Related]
2. [Regulatory effect of Ac-SDKP on phosphorylated heat shock protein 27/SNAI1 pathway in silicotic rats].
Cao W; Yao SS; Gong HB; Zhu LY; Miao ZY; Deng HJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Feb; 40(2):90-96. PubMed ID: 35255573
[No Abstract] [Full Text] [Related]
3. Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
Gao X; Xu H; Zhang B; Tao T; Liu Y; Xu D; Cai W; Wei Z; Li S; Zhang H; Mao N; Zhang G; Li D; Jin F; Li S; Zhang L; Liu H; Hao X; Yang F
Exp Physiol; 2019 Oct; 104(10):1562-1574. PubMed ID: 31290182
[TBL] [Abstract][Full Text] [Related]
4. Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica.
Xiaojun W; Yan L; Hong X; Xianghong Z; Shifeng L; Dingjie X; Xuemin G; Lijuan Z; Bonan Z; Zhongqiu W; Ruimin W; Brann D; Fang Y
Sci Rep; 2016 Aug; 6():32257. PubMed ID: 27577858
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
Wang M; Liu R; Jia X; Mu S; Xie R
Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
[TBL] [Abstract][Full Text] [Related]
6. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat.
Deng H; Xu H; Zhang X; Sun Y; Wang R; Brann D; Yang F
Toxicol Appl Pharmacol; 2016 Mar; 294():1-10. PubMed ID: 26785300
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition effect of N-acetyl-seryl-aspartyl-lysyl-proline on myofibroblast differentiation by regulating acetylated tubulin α in silicotic rat model].
Li S; Gao X; Xu D; Wang X; Liu Y; Zhang L; Deng H; Wei Z; Tian J; Xu H; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Nov; 33(11):816-21. PubMed ID: 26887263
[TBL] [Abstract][Full Text] [Related]
9. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
10. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on differentiation from pulmonary fibroblast to myofibroblast mediated by Rho-associated coiled-coil forming protein kinase pathway].
Yuan Y; Yang F; Xu H; Yu WY; Sun Y; Deng HJ; Ma WD; Wei ZQ; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Sep; 31(9):654-60. PubMed ID: 24064119
[TBL] [Abstract][Full Text] [Related]
11. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
[TBL] [Abstract][Full Text] [Related]
12. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
13. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M
IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390
[TBL] [Abstract][Full Text] [Related]
14. [Comparative proteomic analysis on anti-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in rats with silicosis].
Xu H; Xue X; Du S; Li S; Sun Y; Yuan Y; Deng H; Wei Z; Wang R; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Aug; 32(8):561-7. PubMed ID: 25182983
[TBL] [Abstract][Full Text] [Related]
15. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
Xu H; Yang F; Sun Y; Yuan Y; Cheng H; Wei Z; Li S; Cheng T; Brann D; Wang R
PLoS One; 2012; 7(7):e40301. PubMed ID: 22802960
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Identification of a Novel Peptide, Ac-SDK (Biotin) Proline, That Can Elicit Anti-Fibrosis Effects in Rats Suffering from Silicosis.
Wang J; Qian Y; Gao X; Mao N; Geng Y; Lin G; Zhang G; Li H; Yang F; Xu H
Drug Des Devel Ther; 2020; 14():4315-4326. PubMed ID: 33116418
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
[TBL] [Abstract][Full Text] [Related]
18. Ac-SDKP increases α-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-β1 and silica.
Shifeng L; Hong X; Xue Y; Siyu N; Qiaodan Z; Dingjie X; Lijuan Z; Zhongqiu W; Xuemin G; Wenchen C; Guizhen Z; Dan L; Ruimin W; Fang Y
Toxicol Appl Pharmacol; 2019 Apr; 369():17-29. PubMed ID: 30826375
[TBL] [Abstract][Full Text] [Related]
19. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates silicotic fibrosis by suppressing apoptosis of alveolar type II epithelial cells via mediation of endoplasmic reticulum stress.
Zhang L; Xu D; Li Q; Yang Y; Xu H; Wei Z; Wang R; Zhang W; Liu Y; Geng Y; Li S; Gao X; Yang F
Toxicol Appl Pharmacol; 2018 Jul; 350():1-10. PubMed ID: 29684394
[TBL] [Abstract][Full Text] [Related]
20. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.
Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M
J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
